Assessment of the Optic Nerve Head, Peripapillary, and Macular Microcirculation in the Newly Diagnosed Patients with Primary Open-angle Glaucoma Treated with Topical Tafluprost and Tafluprost/timolol Fixed Combination

Overview

Journal Taiwan J Ophthalmol

Specialty Ophthalmology

Date 2019 Jun 15

PMID 31198667

Citations 6

Authors

Natalia Ivanovna Kurysheva

Affiliations

Soon will be listed here.

Abstract

Relevance: The ability of antiglaucoma drugs to improve ocular hemoperfusion is an important aspect of their action. Tafluprost is the first preservative-free prostaglandin analog. The efficacy and safety of tafluprost, as well as tafluprost/timolol fixed combination (FC), were demonstrated in randomized multicenter trials. However, there is no literature on the effect of tafluprost and its FC on the peripapillary and macular blood flow.

Purpose: To determine the changes of microcirculation in the optic nerve head (ONH), peripapillary retina, and macula in patients with newly diagnosed primary open-angle glaucoma (POAG) under the topical tafluprost and tafluprost/timolol FC treatment.

Materials And Methods: Optical coherence tomography angiography (OCT-A) was performed in dynamics with an interval of a week in 36 patients (36 eyes) with a newly diagnosed initial stage of POAG: 12 eyes with tafluprost, 12 - tafluprost/timolol FC, and 12 - no topical treatment (the control group). The change in intraocular pressure (IOP), mean ocular perfusion pressure (MOPP) of the eye, and vessel density (VD) inside the ONH (inside disc), as well as in the peripapillary retina and macula, was evaluated by comparing paired repeated observations using the median growth analysis.

Results: In the tafluprost group, there were a decrease in IOP by 19.4% and an increase in MOPP by 8.7% from the reference level. In the tafluprost/timolol group, these figures were 43% and 30.1%, respectively. OCT-A values did not change reliably, except for VD inside disc: the median growth of the tafluprost group was 2.28 ( = 0.02) and of the tafluprost/timolol group was 1.82 ( = 0.03). These changes were obtained in 11 of 12 patients in each group under treatment. In control group, all indicators remained unchanged.

Conclusions: A significant increase of MOPP and a decrease of VD in the ONH in patients with initial glaucoma occurred within a week under the topical tafluprost or its FC. This can be explained by the restoration of autoregulation of the ocular blood flow in conditions of pronounced hypotensive effect of the drugs.

Citing Articles

The impact of intraocular pressure on optical coherence tomography angiography: A review of current evidence.

Williams P, Gregory A, Komro J, You Q, Ross B, Colon C Saudi J Ophthalmol. 2024; 38(2):144-151.

PMID: 38988792 PMC: 11232753. DOI: 10.4103/sjopt.sjopt_112_23.

Association of Intraocular Pressure and Optical Coherence Tomography Angiography Parameters in Early Glaucoma Treatment.

Chuang L, Li J, Huang P, Chen H, Liu C, Yang J Diagnostics (Basel). 2022; 12(9).

PMID: 36140574 PMC: 9498188. DOI: 10.3390/diagnostics12092174.

Effects of Tafluprost on Ocular Blood Flow.

Zhang X, Zhou X, Zhao Y, Yang X, Zhou D, Chen B Ophthalmol Ther. 2022; 11(6):1991-2003.

PMID: 36109465 PMC: 9587142. DOI: 10.1007/s40123-022-00566-z.

The characteristics of fundus microvascular alterations in the course of glaucoma: a narrative review.

Fan X, Ying Y, Zhai R, Sheng Q, Sun Y, Xu H Ann Transl Med. 2022; 10(9):527.

PMID: 35928752 PMC: 9347045. DOI: 10.21037/atm-21-5695.

Treatment of open-angle glaucoma and ocular hypertension with preservative-free tafluprost/timolol fixed-dose combination therapy: 6 case reports and clinical outcomes.

Ansari E, Chappiti S, Pavicic-Astalos J, Pinto-Bonilla J, Riva I, Sacchi M BMC Ophthalmol. 2022; 22(1):152.

PMID: 35366846 PMC: 8977001. DOI: 10.1186/s12886-022-02361-7.

References

Takagi Y, Nakajima T, Shimazaki A, Kageyama M, Matsugi T, Matsumura Y . Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug. Exp Eye Res. 2004; 78(4):767-76. DOI: 10.1016/j.exer.2003.12.007. View

Martinez A, Sanchez M . Predictive value of colour Doppler imaging in a prospective study of visual field progression in primary open-angle glaucoma. Acta Ophthalmol Scand. 2006; 83(6):716-22. DOI: 10.1111/j.1600-0420.2005.00567.x. View

Dong Y, Watabe H, Su G, Ishikawa H, Sato N, Yoshitomi T . Relaxing effect and mechanism of tafluprost on isolated rabbit ciliary arteries. Exp Eye Res. 2008; 87(3):251-6. DOI: 10.1016/j.exer.2008.06.005. View

Izumi N, Nagaoka T, Sato E, Mori F, Takahashi A, Sogawa K . Short-term effects of topical tafluprost on retinal blood flow in cats. J Ocul Pharmacol Ther. 2008; 24(5):521-6. DOI: 10.1089/jop.2007.0065. View

Traverso C, Ropo A, Papadia M, Uusitalo H . A phase II study on the duration and stability of the intraocular pressure-lowering effect and tolerability of Tafluprost compared with latanoprost. J Ocul Pharmacol Ther. 2010; 26(1):97-104. DOI: 10.1089/jop.2009.0066. View

Akaishi T, Kurashima H, Odani-Kawabata N, Ishida N, Nakamura M . Effects of repeated administrations of tafluprost, latanoprost, and travoprost on optic nerve head blood flow in conscious normal rabbits. J Ocul Pharmacol Ther. 2010; 26(2):181-6. DOI: 10.1089/jop.2009.0100. View

Mayama C, Ishii K, Saeki T, Ota T, Tomidokoro A, Araie M . Effects of topical phenylephrine and tafluprost on optic nerve head circulation in monkeys with unilateral experimental glaucoma. Invest Ophthalmol Vis Sci. 2010; 51(8):4117-24. DOI: 10.1167/iovs.10-5218. View

Uusitalo H, Pillunat L, Ropo A . Efficacy and safety of tafluprost 0.0015% versus latanoprost 0.005% eye drops in open-angle glaucoma and ocular hypertension: 24-month results of a randomized, double-masked phase III study. Acta Ophthalmol. 2010; 88(1):12-9. DOI: 10.1111/j.1755-3768.2010.01862.x. View

Hommer A, Mohammed Ramez O, Burchert M, Kimmich F . IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma. Curr Med Res Opin. 2010; 26(8):1905-13. DOI: 10.1185/03007995.2010.492030. View

10.

Kurashima H, Watabe H, Sato N, Abe S, Ishida N, Yoshitomi T . Effects of prostaglandin F(2α) analogues on endothelin-1-induced impairment of rabbit ocular blood flow: comparison among tafluprost, travoprost, and latanoprost. Exp Eye Res. 2010; 91(6):853-9. DOI: 10.1016/j.exer.2010.09.004. View

11.

Aptel F, Cucherat M, Denis P . Efficacy and tolerability of prostaglandin-timolol fixed combinations: a meta-analysis of randomized clinical trials. Eur J Ophthalmol. 2011; 22(1):5-18. DOI: 10.5301/ejo.5000009. View

12.

Jia Y, Morrison J, Tokayer J, Tan O, Lombardi L, Baumann B . Quantitative OCT angiography of optic nerve head blood flow. Biomed Opt Express. 2012; 3(12):3127-37. PMC: 3521313. DOI: 10.1364/BOE.3.003127. View

13.

Tsuda S, Yokoyama Y, Chiba N, Aizawa N, Shiga Y, Yasuda M . Effect of topical tafluprost on optic nerve head blood flow in patients with myopic disc type. J Glaucoma. 2013; 22(5):398-403. DOI: 10.1097/IJG.0b013e318237c8b3. View

14.

Konstas A, Quaranta L, Katsanos A, Riva I, Tsai J, Giannopoulos T . Twenty-four hour efficacy with preservative free tafluprost compared with latanoprost in patients with primary open angle glaucoma or ocular hypertension. Br J Ophthalmol. 2013; 97(12):1510-5. DOI: 10.1136/bjophthalmol-2012-303026. View

15.

Hollo G, Hommer A, Anton Lopez A, Ropo A . Efficacy, safety, and tolerability of preservative-free fixed combination of tafluprost 0.0015%/timolol 0.5% versus concomitant use of the ingredients. J Ocul Pharmacol Ther. 2014; 30(6):468-75. DOI: 10.1089/jop.2013.0229. View

16.

Pfeiffer N, Traverso C, Lorenz K, Saarela V, Liinamaa J, Uusitalo H . A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components. Adv Ther. 2014; 31(12):1228-46. PMC: 4271134. DOI: 10.1007/s12325-014-0163-3. View

17.

Tobe L, Harris A, Hussain R, Eckert G, Huck A, Park J . The role of retrobulbar and retinal circulation on optic nerve head and retinal nerve fibre layer structure in patients with open-angle glaucoma over an 18-month period. Br J Ophthalmol. 2014; 99(5):609-12. DOI: 10.1136/bjophthalmol-2014-305780. View

18.

Pechauer A, Jia Y, Liu L, Gao S, Jiang C, Huang D . Optical Coherence Tomography Angiography of Peripapillary Retinal Blood Flow Response to Hyperoxia. Invest Ophthalmol Vis Sci. 2015; 56(5):3287-91. PMC: 4453965. DOI: 10.1167/iovs.15-16655. View

19.

Hoy S . Tafluprost/Timolol: A Review in Open-Angle Glaucoma or Ocular Hypertension. Drugs. 2015; 75(15):1807-13. DOI: 10.1007/s40265-015-0476-9. View

20.

Seo D, Ha S . Comparison of Ocular Pulse Amplitude Lowering Effects of Preservative-Free Tafluprost and Preservative-Free Dorzolamide-Timolol Fixed Combination Eyedrops. Biomed Res Int. 2015; 2015:435874. PMC: 4628750. DOI: 10.1155/2015/435874. View